Similarly, malabsorption of carbohydrate induced by an α-glucosidase inhibitor (e.g., acarbose) was shown to increase GLP-1 and PYY secretion in both health and T2DM [171,172]. This evidence concerns the gene GCG and type 2 diabetes mellitus.